Skip to main content
Tech.euFundingExplorerBeta
Funding rounds/OMass Therapeutics

OMass Therapeutics

Series B
Oxford, UKApr 2022
Healthtech

OMass Therapeutics raised €90M in a Series B round in Apr 2022. The company is based in Oxford, UK. Investors in the round: GV, Northpond Ventures, Oxford Science Enterprises and 3 others. Data as of Nov 2026.

← OMass Therapeutics
Amount raised
€90M
€89,508,002
Native amount
75,500,000 GBP
Stage
Series B
series b
Investors
6

Provenance & confidence

High confidence
Amount
75,500,000 GBP
ECB-at-date → €90M · rate 0.8435 on 2022-04-28
High confidence
Source

businesscloud.co.uk · established

High confidence

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

Investors in this round

6 named
GVNorthpond VenturesOxford Science EnterprisesOxford University Innovation FundSanofi VenturesSyncona Partners
Date
Apr 2022
Round type
series b
Amount (EUR)
€90M

Other rounds

same company

Related news